{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:27:28Z","timestamp":1761719248018,"version":"3.30.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bbadis.2023.166836","type":"journal-article","created":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T06:00:32Z","timestamp":1691215232000},"page":"166836","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["SARS-CoV-2 variants, its recombinants and epigenomic exploitation of host defenses"],"prefix":"10.1016","volume":"1869","author":[{"given":"Nitin K.","family":"Saksena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasa Bonam","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Miranda-Saksena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thyago H.S.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edson M.A.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana C.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael M.","family":"Rabeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2023.166836_bb0005","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.581726","article-title":"Epigenetic lens to visualize the severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) infection in COVID-19 pandemic","volume":"12","author":"Saksena","year":"2021","journal-title":"Front. Genet."},{"issue":"14","key":"10.1016\/j.bbadis.2023.166836_bb0010","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1128\/JVI.01244-13","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","volume":"87","author":"de Groot","year":"2013","journal-title":"J. Virol."},{"issue":"9997","key":"10.1016\/j.bbadis.2023.166836_bb0015","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(15)60454-8","article-title":"Middle East respiratory syndrome","volume":"386","author":"Zumla","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bbadis.2023.166836_bb0020","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/v11020174","article-title":"Global epidemiology of bat coronaviruses","volume":"11","author":"Wong","year":"2019","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.bbadis.2023.166836_bb0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.24272\/j.issn.2095-8137.2020.031","article-title":"Zoonotic origins of human coronavirus 2019 (HCoV-19\/SARS-CoV-2): why is this work important?","volume":"41","author":"Wong","year":"2020","journal-title":"Zool. Res."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166836_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/M20-3905","article-title":"Patient trajectories among persons hospitalized for COVID-19: a cohort study","volume":"174","author":"Garibaldi","year":"2021","journal-title":"Ann. Intern. Med."},{"issue":"20","key":"10.1016\/j.bbadis.2023.166836_bb0035","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1001\/jama.2020.20717","article-title":"COVID-19 and excess all-cause mortality in the US and 18 comparison countries","volume":"324","author":"Bilinski","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.bbadis.2023.166836_bb0040","unstructured":"Worldometer, https:\/\/www.worldometers.info\/coronavirus\/."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166836_bb0045","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0022-2836(03)00865-9","article-title":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage","volume":"331","author":"Snijder","year":"2003","journal-title":"J. Mol. Biol."},{"issue":"12","key":"10.1016\/j.bbadis.2023.166836_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166527","article-title":"Epigenetic perspectives of COVID-19: virus infection to disease progression and therapeutic control","volume":"1868","author":"Patra","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"6","key":"10.1016\/j.bbadis.2023.166836_bb0055","doi-asserted-by":"crossref","first-page":"794","DOI":"10.37349\/ei.2022.00084","article-title":"Incursions by severe acute respiratory syndrome coronavirus-2 on the host anti-viral immunity during mild, moderate, and severe coronavirus disease 2019 disease","volume":"2","author":"Nitin","year":"2022","journal-title":"Exploration of Medicine"},{"issue":"5","key":"10.1016\/j.bbadis.2023.166836_bb0060","doi-asserted-by":"crossref","first-page":"E1012","DOI":"10.1073\/pnas.1706928115","article-title":"MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape","volume":"115","author":"Menachery","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7390","key":"10.1016\/j.bbadis.2023.166836_bb0065","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature10892","article-title":"Suppression of the antiviral response by an influenza histone mimic","volume":"483","author":"Marazzi","year":"2012","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bbadis.2023.166836_bb0070","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Lopez-Otin","year":"2013","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.bbadis.2023.166836_bb0075","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/gerona\/glaa149","article-title":"COVID-19 and crosstalk with the hallmarks of aging","volume":"75","author":"Salimi","year":"2020","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166836_bb0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/pathogens6010008","article-title":"Epigenetic landscape during coronavirus infection","volume":"6","author":"Schafer","year":"2017","journal-title":"Pathogens"},{"key":"10.1016\/j.bbadis.2023.166836_bb0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.virusres.2018.01.014","article-title":"Codon usage variation of Zika virus: the potential roles of NS2B and NS4A in its global pandemic","volume":"247","author":"Lin","year":"2018","journal-title":"Virus Res."},{"issue":"24","key":"10.1016\/j.bbadis.2023.166836_bb0090","doi-asserted-by":"crossref","first-page":"9411","DOI":"10.3390\/ijerph17249411","article-title":"Viral pandemics of the last four decades: pathophysiology, health impacts and perspectives","volume":"17","author":"Roychoudhury","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"8","key":"10.1016\/j.bbadis.2023.166836_bb0095","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.4103\/jfmpc.jfmpc_2071_20","article-title":"Viral pandemics in the past two decades: an overview","volume":"10","author":"Bhadoria","year":"2021","journal-title":"J Family Med Prim Care"},{"issue":"11","key":"10.1016\/j.bbadis.2023.166836_bb0100","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2217\/fvl-2021-0215","article-title":"New viruses on the rise: a one health and ecosystem-based perspective on emerging viruses","volume":"16","author":"Ergunay","year":"2021","journal-title":"Future Virol."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166836_bb0105","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1089\/aid.2007.0056","article-title":"Near full-length sequence analysis of a unique CRF01_AE\/B recombinant from Kuala Lumpur, Malaysia","volume":"23","author":"Lau","year":"2007","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166836_bb0110","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/QAD.0b013e3282f82b6c","article-title":"The possible contribution of HIV-1-induced syncytia to the generation of intersubtype recombinants in vitro","volume":"22","author":"Steain","year":"2008","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.bbadis.2023.166836_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251368","article-title":"SARS-CoV-2: possible recombination and emergence of potentially more virulent strains","volume":"16","author":"Haddad","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2023.166836_bb0120","article-title":"Deltacron: new variant or laboratory error?","author":"Lang","year":"2022","journal-title":"Medical News Today"},{"year":"2022","series-title":"Tracking SARS-CoV-2 variants","key":"10.1016\/j.bbadis.2023.166836_bb0125"},{"issue":"7","key":"10.1016\/j.bbadis.2023.166836_bb0130","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2471\/BLT.20.253591","article-title":"Variant analysis of SARS-CoV-2 genomes","volume":"98","author":"Koyama","year":"2020","journal-title":"Bull. World Health Organ."},{"year":"2020","series-title":"SARS-CoV-2 Variant Classifications and Definitions","key":"10.1016\/j.bbadis.2023.166836_bb0135"},{"issue":"32","key":"10.1016\/j.bbadis.2023.166836_bb0140","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.32.2001410","article-title":"Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020","volume":"25","author":"Alm","year":"2020","journal-title":"Euro Surveill."},{"year":"2021","series-title":"SARS-CoV-2 Variant Classifications and Definitions","key":"10.1016\/j.bbadis.2023.166836_bb0145"},{"year":"2021","series-title":"Explainer: What Is the Delta Variant of Coronavirus with K417N Mutation?","author":"Acharya","key":"10.1016\/j.bbadis.2023.166836_bb0150"},{"year":"2021","series-title":"SARS-CoV-2 Variants of Concern and Variants Under Investigation in England, Technical Briefing 17","key":"10.1016\/j.bbadis.2023.166836_bb0155"},{"year":"2022","series-title":"Weekly Epidemiological Update on COVID-19 - 26 October 2022","key":"10.1016\/j.bbadis.2023.166836_bb0160"},{"year":"2022","series-title":"What We Know about Omicron\u2019s BA.2 Variant So Far","author":"Schmidt","key":"10.1016\/j.bbadis.2023.166836_bb0165"},{"issue":"11","key":"10.1016\/j.bbadis.2023.166836_bb0170","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.chom.2022.10.003","article-title":"Virological characteristics of the SARS-CoV-2 omicron BA.2.75 variant","volume":"30","author":"Saito","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166836_bb0175","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/cid\/ciab283","article-title":"Estimation of secondary household attack rates for emergent spike L452R severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants detected by genomic surveillance at a community-based testing site in San Francisco","volume":"74","author":"Peng","year":"2022","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166836_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26055-8","article-title":"Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions","volume":"12","author":"Dudas","year":"2021","journal-title":"Nat Commun"},{"issue":"633","key":"10.1016\/j.bbadis.2023.166836_bb0185","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abk3445","article-title":"Predicting the mutational drivers of future SARS-CoV-2 variants of concern","volume":"14","author":"Maher","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"20","key":"10.1016\/j.bbadis.2023.166836_bb0190","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1016\/j.cell.2021.08.014","article-title":"Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic","volume":"184","author":"Jackson","year":"2021","journal-title":"Cell"},{"issue":"27","key":"10.1016\/j.bbadis.2023.166836_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb9153","article-title":"Emergence of SARS-CoV-2 through recombination and strong purifying selection","volume":"6","author":"Li","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.bbadis.2023.166836_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2022.106670","article-title":"Recombinant SARS-CoV-2 variants XD, XE, and XF: the emergence of recombinant variants requires an urgent call for research - correspondence","volume":"102","author":"Chakraborty","year":"2022","journal-title":"Int. J. Surg."},{"issue":"7929","key":"10.1016\/j.bbadis.2023.166836_bb0205","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41586-022-05189-9","article-title":"Pandemic-scale phylogenomics reveals the SARS-CoV-2 recombination landscape","volume":"609","author":"Turakhia","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2023.166836_bb0210","article-title":"Rapid expansion of SARS-CoV-2 variants of concern is a result of adaptive epistasis","author":"Garvin","year":"2021","journal-title":"bioRxiv"},{"issue":"6599","key":"10.1016\/j.bbadis.2023.166836_bb0215","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1126\/science.abm1208","article-title":"Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness","volume":"376","author":"Obermeyer","year":"2022","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.bbadis.2023.166836_bb0220","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl5394","article-title":"High-resolution profiling of MHC II peptide presentation capacity reveals SARS-CoV-2 CD4 T cell targets and mechanisms of immune escape","volume":"8","author":"Obermair","year":"2022","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166836_bb0225","doi-asserted-by":"crossref","DOI":"10.1093\/ve\/veac021","article-title":"An antibody-escape estimator for mutations to the SARS-CoV-2 receptor-binding domain","volume":"8","author":"Greaney","year":"2022","journal-title":"Virus Evol"},{"issue":"16","key":"10.1016\/j.bbadis.2023.166836_bb0230","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMc2201849","article-title":"Neutralization of the SARS-CoV-2 omicron BA.1 and BA.2 variants","volume":"386","author":"Yu","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"6575","key":"10.1016\/j.bbadis.2023.166836_bb0235","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.abl6184","article-title":"Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles","volume":"374","author":"Syed","year":"2021","journal-title":"Science"},{"issue":"7852","key":"10.1016\/j.bbadis.2023.166836_bb0240","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41586-021-03361-1","article-title":"SARS-CoV-2 spike D614G change enhances replication and transmission","volume":"592","author":"Zhou","year":"2021","journal-title":"Nature"},{"issue":"7896","key":"10.1016\/j.bbadis.2023.166836_bb0245","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41586-021-04245-0","article-title":"The N501Y spike substitution enhances SARS-CoV-2 infection and transmission","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbadis.2023.166836_bb0250","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin. Immunopathol."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166836_bb0255","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.chom.2016.04.008","article-title":"Epigenetics and genetics of viral latency","volume":"19","author":"Lieberman","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.bbadis.2023.166836_bb0260","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mib.2015.06.009","article-title":"Interference of viral effector proteins with chromatin, transcription, and the epigenome","volume":"26","author":"Marazzi","year":"2015","journal-title":"Curr. Opin. Microbiol."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166836_bb0265","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.chom.2014.10.004","article-title":"Adenovirus small E1A employs the lysine acetylases p300\/CBP and tumor suppressor Rb to repress select host genes and promote productive virus infection","volume":"16","author":"Ferrari","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"Pt 4","key":"10.1016\/j.bbadis.2023.166836_bb0270","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1099\/vir.0.000032","article-title":"Hepatitis C virus core protein overcomes H2O2-induced apoptosis by downregulating p14 expression via DNA methylation","volume":"96","author":"Seo","year":"2015","journal-title":"J. Gen. Virol."},{"issue":"3","key":"10.1016\/j.bbadis.2023.166836_bb0275","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01174-14","article-title":"Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses","volume":"5","author":"Menachery","year":"2014","journal-title":"mBio"},{"issue":"19","key":"10.1016\/j.bbadis.2023.166836_bb0280","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1016\/j.cell.2021.08.016","article-title":"The interferon landscape along the respiratory tract impacts the severity of COVID-19","volume":"184","author":"Sposito","year":"2021","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.bbadis.2023.166836_bb0285","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/JVI.02472-07","article-title":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells","volume":"82","author":"Narayanan","year":"2008","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.bbadis.2023.166836_bb0290","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1128\/JVI.80.2.785-793.2006","article-title":"7a protein of severe acute respiratory syndrome coronavirus inhibits cellular protein synthesis and activates p38 mitogen-activated protein kinase","volume":"80","author":"Kopecky-Bromberg","year":"2006","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166836_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001494","article-title":"Coronavirus spike protein inhibits host cell translation by interaction with eIF3f","volume":"3","author":"Xiao","year":"2008","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.bbadis.2023.166836_bb0300","doi-asserted-by":"crossref","first-page":"6962","DOI":"10.1128\/JVI.00133-08","article-title":"The nucleocapsid protein of severe acute respiratory syndrome coronavirus inhibits cell cytokinesis and proliferation by interacting with translation elongation factor 1alpha","volume":"82","author":"Zhou","year":"2008","journal-title":"J. Virol."},{"issue":"24","key":"10.1016\/j.bbadis.2023.166836_bb0305","doi-asserted-by":"crossref","first-page":"13598","DOI":"10.1128\/JVI.01958-12","article-title":"Severe acute respiratory syndrome coronavirus protein nsp1 is a novel eukaryotic translation inhibitor that represses multiple steps of translation initiation","volume":"86","author":"Lokugamage","year":"2012","journal-title":"J. Virol."},{"issue":"6508","key":"10.1016\/j.bbadis.2023.166836_bb0310","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1126\/science.abc8665","article-title":"Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2","volume":"369","author":"Thoms","year":"2020","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.bbadis.2023.166836_bb0315","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/s41594-020-0511-8","article-title":"SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation","volume":"27","author":"Schubert","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"30","key":"10.1016\/j.bbadis.2023.166836_bb0320","doi-asserted-by":"crossref","first-page":"9436","DOI":"10.1073\/pnas.1508686112","article-title":"Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex","volume":"112","author":"Ma","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.bbadis.2023.166836_bb0325","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1073\/pnas.0808790106","article-title":"Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"24","key":"10.1016\/j.bbadis.2023.166836_bb0330","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101161118","article-title":"Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein","volume":"118","author":"Hsu","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"37","key":"10.1016\/j.bbadis.2023.166836_bb0335","doi-asserted-by":"crossref","first-page":"25783","DOI":"10.1074\/jbc.M114.577353","article-title":"Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes","volume":"289","author":"Bouvet","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166836_bb0340","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S2213-2600(20)30566-X","article-title":"Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial","volume":"9","author":"Feld","year":"2021","journal-title":"Lancet Respir Med"},{"year":"2022","series-title":"Eiger's Single-dose Peginterferon Lambda for COVID-19 Reduced Risk of Hospitalization or ER Visits by 50% in a Predominantly Vaccinated Population in Phase 3 TOGETHER Study","key":"10.1016\/j.bbadis.2023.166836_bb0345"},{"issue":"6","key":"10.1016\/j.bbadis.2023.166836_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110799","article-title":"Nasally delivered interferon-lambda protects mice against infection by SARS-CoV-2 variants including omicron","volume":"39","author":"Chong","year":"2022","journal-title":"Cell Rep."},{"issue":"7897","key":"10.1016\/j.bbadis.2023.166836_bb0355","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41586-021-04352-y","article-title":"Evolution of enhanced innate immune evasion by SARS-CoV-2","volume":"602","author":"Thorne","year":"2022","journal-title":"Nature"},{"issue":"7858","key":"10.1016\/j.bbadis.2023.166836_bb0360","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41586-021-03470-x","article-title":"Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England","volume":"593","author":"Volz","year":"2021","journal-title":"Nature"},{"issue":"6538","key":"10.1016\/j.bbadis.2023.166836_bb0365","doi-asserted-by":"crossref","DOI":"10.1126\/science.abg3055","article-title":"Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England","volume":"372","author":"Davies","year":"2021","journal-title":"Science"},{"issue":"7816","key":"10.1016\/j.bbadis.2023.166836_bb0370","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2023.166836_bb0375","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ijid.2021.03.005","article-title":"Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs","volume":"105","author":"Calistri","year":"2021","journal-title":"Int. J. Infect. Dis."},{"issue":"7835","key":"10.1016\/j.bbadis.2023.166836_bb0380","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","article-title":"Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity","volume":"587","author":"Shin","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166836_bb0385","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1080\/22221751.2020.1780953","article-title":"SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists","volume":"9","author":"Yuen","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"7","key":"10.1016\/j.bbadis.2023.166836_bb0390","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.4049\/jimmunol.174.7.4120","article-title":"Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells","volume":"174","author":"Ouellet","year":"2005","journal-title":"J. Immunol."},{"issue":"15","key":"10.1016\/j.bbadis.2023.166836_bb0395","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1021\/bi972521d","article-title":"Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis","volume":"37","author":"Schick","year":"1998","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.bbadis.2023.166836_bb0400","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1128\/MCB.01466-09","article-title":"Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification","volume":"30","author":"Shi","year":"2010","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166836_bb0405","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166836_bb0410","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/22221751.2020.1870414","article-title":"SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species","volume":"10","author":"Moustaqil","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.bbadis.2023.166836_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155697","article-title":"SARS-CoV-2 3C-like protease antagonizes interferon-beta production by facilitating the degradation of IRF3","volume":"148","author":"Zhang","year":"2021","journal-title":"Cytokine"},{"issue":"7902","key":"10.1016\/j.bbadis.2023.166836_bb0420","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","article-title":"SARS-CoV-2 omicron variant replication in human bronchus and lung ex vivo","volume":"603","author":"Hui","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bbadis.2023.166836_bb0425","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/s41564-022-01135-7","article-title":"Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of omicron in Australia","volume":"7","author":"Aggarwal","year":"2022","journal-title":"Nat. Microbiol."},{"issue":"7902","key":"10.1016\/j.bbadis.2023.166836_bb0430","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 usage by SARS-CoV-2 omicron impacts infectivity and fusogenicity","volume":"603","author":"Meng","year":"2022","journal-title":"Nature"},{"issue":"32","key":"10.1016\/j.bbadis.2023.166836_bb0435","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2203760119","article-title":"Interferon resistance of emerging SARS-CoV-2 variants","volume":"119","author":"Guo","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2023.166836_bb0440","unstructured":"Terms of Reference for the Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE), https:\/\/www.who.int\/publications\/m\/item\/terms-of-reference-for-the-technical-advisory-group-on-sars-cov-2-virus-evolution-(tag-ve), 2021."},{"key":"10.1016\/j.bbadis.2023.166836_bb0445","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.826074","article-title":"Role of HLA-G in viral infections","volume":"13","author":"Jasinski-Bergner","year":"2022","journal-title":"Front. Immunol."},{"year":"2020","series-title":"DNA Methylation Analysis of the COVID-19 Host Cell Receptor, Angiotensin I Converting Enzyme 2 Gene (ACE2) in the Respiratory System Reveal Age and Gender Differences","author":"Corley","key":"10.1016\/j.bbadis.2023.166836_bb0450"},{"key":"10.1016\/j.bbadis.2023.166836_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108410","article-title":"Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients","volume":"215","author":"Sawalha","year":"2020","journal-title":"Clin. Immunol."},{"issue":"8","key":"10.1016\/j.bbadis.2023.166836_bb0460","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1373\/clinchem.2010.148007","article-title":"Epigenomics-based diagnostics","volume":"56","author":"Diamandis","year":"2010","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.bbadis.2023.166836_bb0465","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s43856-021-00042-y","article-title":"Host methylation predicts SARS-CoV-2 infection and clinical outcome","volume":"1","author":"Konigsberg","year":"2021","journal-title":"Commun Med (Lond)"},{"issue":"4","key":"10.1016\/j.bbadis.2023.166836_bb0470","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.bbrc.2005.02.101","article-title":"Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population","volume":"329","author":"Hamano","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6515","key":"10.1016\/j.bbadis.2023.166836_bb0475","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"7848","key":"10.1016\/j.bbadis.2023.166836_bb0480","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","article-title":"Genetic mechanisms of critical illness in COVID-19","volume":"591","author":"Pairo-Castineira","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166836_bb0485","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2334-6-106","article-title":"Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study","volume":"6","author":"He","year":"2006","journal-title":"BMC Infect. Dis."},{"issue":"11","key":"10.1016\/j.bbadis.2023.166836_bb0490","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s13238-021-00836-9","article-title":"High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors","volume":"12","author":"Zhao","year":"2021","journal-title":"Protein Cell"},{"issue":"18","key":"10.1016\/j.bbadis.2023.166836_bb0495","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106275","article-title":"Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2","volume":"39","author":"Klemm","year":"2020","journal-title":"EMBO J."},{"issue":"10","key":"10.1016\/j.bbadis.2023.166836_bb0500","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1177\/2472555220963667","article-title":"High-throughput screening for drugs that inhibit papain-like protease in SARS-CoV-2","volume":"25","author":"Smith","year":"2020","journal-title":"SLAS Discov"},{"issue":"6557","key":"10.1016\/j.bbadis.2023.166836_bb0505","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1126\/science.abg5827","article-title":"Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2","volume":"373","author":"Drayman","year":"2021","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bbadis.2023.166836_bb0510","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s42003-020-01577-x","article-title":"Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents","volume":"4","author":"Mody","year":"2021","journal-title":"Commun Biol"},{"issue":"20","key":"10.1016\/j.bbadis.2023.166836_bb0515","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1042\/BCJ20220380","article-title":"Therapeutic potential of metal ions for COVID-19: insights from the papain-like protease of SARS-CoV-2","volume":"479","author":"Shetler","year":"2022","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.bbadis.2023.166836_bb0520","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s12276-021-00592-0","article-title":"Type I and III interferon responses in SARS-CoV-2 infection","volume":"53","author":"Kim","year":"2021","journal-title":"Exp Mol Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923002028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443923002028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T17:25:09Z","timestamp":1733073909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443923002028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":104,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0925443923002028"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166836","relation":{},"ISSN":["0925-4439"],"issn-type":[{"type":"print","value":"0925-4439"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 variants, its recombinants and epigenomic exploitation of host defenses","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2023.166836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166836"}}